A detailed history of Advisor Group Holdings, Inc. transactions in Immucell Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 391 shares of ICCC stock, worth $2,502. This represents 0.0% of its overall portfolio holdings.

Number of Shares
391
Holding current value
$2,502
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$4.62 - $5.5 $1,806 - $2,150
391 New
391 $1,000
Q4 2023

Feb 12, 2024

BUY
$4.45 - $5.47 $2,447 - $3,008
550 New
550 $2,000
Q2 2023

Aug 10, 2023

BUY
$4.64 - $5.98 $2,552 - $3,289
550 New
550 $2,000

Others Institutions Holding ICCC

About IMMUCELL CORP


  • Ticker ICCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,746,860
  • Market Cap $49.6M
  • Description
  • ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...
More about ICCC
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.